Empower Advisory Group’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.2M Buy
1,033,523
+40,640
+4% +$2.97M 0.17% 113
2026
Q1
$75.8M Buy
992,883
+43,690
+5% +$3.15M 0.2% 103
2025
Q4
$60.6M Buy
949,193
+38,865
+4% +$2.4M 0.16% 111
2025
Q3
$57.4M Buy
910,328
+28,701
+3% +$2M 0.16% 120
2025
Q2
$65.8M Buy
881,627
+16,191
+2% +$1.27M 0.2% 105
2025
Q1
$76.3M Sell
865,436
-11,095
-1% -$1.05M 0.25% 85
2024
Q4
$80M Buy
876,531
+24,600
+3% +$2.52M 0.27% 73
2024
Q3
$95.4M Buy
851,931
+20,552
+2% +$2.06M 0.32% 65
2024
Q2
$81.5M Buy
831,379
+3,077
+0.4% +$305K 0.3% 68
2024
Q1
$83M Buy
828,302
+25,972
+3% +$2.28M 0.31% 71
2023
Q4
$72.1M Buy
802,330
+77,368
+11% +$6.17M 0.28% 76
2023
Q3
$55.6M Sell
724,962
-12,701
-2% -$1.05M 0.25% 85
2023
Q2
$61.8M Buy
737,663
+46,289
+7% +$3.76M 0.27% 81
2023
Q1
$58.4M Buy
+691,374
New +$59.4M 0.26% 89

Other funds holding EMN

Empower Advisory Group's EMN Position: Q2 2026 in Review

Empower Advisory Group increased its Eastman Chemical (EMN) stake by 4.1% in Q2 2026, buying an estimated $2.97M and bringing the position to 1,033,523 shares worth $69.2M. The position accounts for 0.17% of the portfolio, ranked #113.

Empower Advisory Group first reported a position in EMN in Q1 2023 and has held it in 14 quarters since. The position peaked at $95.4M in Q3 2024. 644 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Empower Advisory Group held 1,033,523 shares of Eastman Chemical worth $69.2M as of Q2 2026.
  • Empower Advisory Group bought 40,640 Eastman Chemical shares in Q2 2026, an estimated $2.97M.
  • Eastman Chemical made up 0.17% of Empower Advisory Group's portfolio in Q2 2026, its #113 holding.
  • Empower Advisory Group first reported a position in Eastman Chemical in Q1 2023 and has held it in 14 quarters since.
  • Empower Advisory Group's Eastman Chemical position peaked at $95.4M in Q3 2024.
  • 644 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.